Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,100 public trials 1,371 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Study of Ramucirumab in Ovarian Cancer

NCT00721162

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • ImClone Investigational Site Hollywood, Florida, United States
  • ImClone Investigational Site Orlando, Florida, United States
  • ImClone Investigational Site Chicago, Illinois, United States
  • ImClone Investigational Site Marrero, Louisiana, United States
View all 13 locations
View Trial Details
Completed

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

NCT00913835

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • ImClone Investigational Site Joliet, Illinois, United States
  • ImClone Investigational Site Indianapolis, Indiana, United States
  • ImClone Investigational Site Baltimore, Maryland, United States
  • ImClone Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01666444

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Winthrop P. Rockefeller Cancer Institute - University of Arkansas Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 136 locations
View Trial Details
Completed

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

NCT00781911

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site Atlanta, Georgia, United States
View Trial Details
Completed

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

NCT01505530

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States
View all 21 locations
View Trial Details
Completed

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

NCT01059643

Conditions
Adnexal Diseases, Bronchial Neoplasms, Cancer of Head and Neck, +46 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Macon, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marietta, Georgia, United States
View all 18 locations
View Trial Details

Related conditions